The Royal Society of Medicine: Whole genome sequencing - The future of newborn screening in the UK?

Should every baby born in the UK have their genome sequenced? Could this help detect and treat severe genetic diseases in childhood? Can we balance the potential benefit to families with ethical concerns that come with the territory?

Tune into this interactive webinar to hear experts from the world of newborn screening, genomics, and patient advocacy discuss the nuances of these topics as the pilot for the newborn WGS programme comes closer to launch. Attendees will be able to take part in the public Q&A panels and have their say.

The purpose of this meeting is to provide an interactive day of talks and panel discussions exploring newborn screening in the UK, and how it may be re-shaped by the introduction of whole genome sequencing.

Several people from Genomics England will be speaking at the conference, including:

• Amanda Pichini, Clinical Lead for Genetic Counselling
• David Bick, Principal Clinician - Newborn Genomes Programme

Benefits of attending:

• Enhance your understanding of the history and purpose of newborn screening in the UK
• Understand the impact of newborn screening on families with rare diseases
• Understand the purpose and structure of the upcoming newborn WGS pilot programme
• Understand the ethical concerns about the newborn WGS pilot